- Author:
Jongun LEE
1
;
Eun Hui BAE
;
Seong Kwon MA
;
Soo Wan KIM
Author Information
- Publication Type:Review
- Keywords: Nitric oxide; Hypertension; Atherosclerosis; Ischemia/reperfusion injury; Heart failure; Nephrogenic diabetes insipidus; Ureteral obstruction; Cardio-renal syndrome
- MeSH: Acetylcholine; Animals; Aquaporin 2; Atherosclerosis; Blood Pressure; Cardio-Renal Syndrome; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Mice; Myocardial Infarction; Myocardium; Neurons; Nitric Oxide; Rats; Relaxation; Renal Insufficiency, Chronic; Risk Factors; Tissue Donors; Ureteral Obstruction
- From:Chonnam Medical Journal 2016;52(2):81-90
- CountryRepublic of Korea
- Language:English
- Abstract: Nitric oxide (NO) is synthesized by a family of NO synthases (NOS), including neuronal, inducible, and endothelial NOS (n/i/eNOS). NO-mediated effects can be beneficial or harmful depending on the specific risk factors affecting the disease. In hypertension, the vascular relaxation response to acetylcholine is blunted, and that to direct NO donors is maintained. A reduction in the activity of eNOS is mainly responsible for the elevation of blood pressure, and an abnormal expression of iNOS is likely to be related to the progression of vascular dysfunction. While eNOS/nNOS-derived NO is protective against the development of atherosclerosis, iNOS-derived NO may be proatherogenic. eNOS-derived NO may prevent the progression of myocardial infarction. Myocardial ischemia/reperfusion injury is significantly enhanced in eNOS-deficient animals. An important component of heart failure is the loss of coronary vascular eNOS activity. A pressure-overload may cause severer left ventricular hypertrophy and dysfunction in eNOS null mice than in wild-type mice. iNOS-derived NO has detrimental effects on the myocardium. NO plays an important role in regulating the angiogenesis and slowing the interstitial fibrosis of the obstructed kidney. In unilateral ureteral obstruction, the expression of eNOS was decreased in the affected kidney. In triply n/i/eNOS null mice, nephrogenic diabetes insipidus developed along with reduced aquaporin-2 abundance. In chronic kidney disease model of subtotal-nephrectomized rats, treatment with NOS inhibitors decreased systemic NO production and induced left ventricular systolic dysfunction (renocardiac syndrome).